CURRENT MEDICAL DIAGNOSIS AND
TREATMENT 2026
65TH EDITION
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
1)
Reference
Ch. Disease Prevention & Health
Promotion — Colorectal Cancer
Screening: Age & Modality Selection
,Stem
A 52-year-old man with no symptoms
and no family history of colorectal cancer
presents for routine preventive care. He
has well-controlled hypertension and
prefers noninvasive testing. He asks
whether fecal immunochemical testing
(FIT) every year is acceptable versus
colonoscopy now. Which is the best
recommendation?
Options
A. Recommend annual FIT as equivalent
to colonoscopy and continue yearly FIT.
B. Recommend flexible sigmoidoscopy
every 5 years because it is less invasive
than colonoscopy.
C. Recommend colonoscopy now
,because he is over 50 and prefers the
most sensitive test.
D. Recommend no screening until age 55
because he is low risk.
Correct answer
A
Rationale — Correct (A)
Annual FIT is an accepted, evidence-
based screening option for average-risk
adults beginning at age 45–50
(depending on guideline) and is
appropriate for patients who prefer a
noninvasive strategy. When performed
annually, FIT yields high sensitivity for
advanced neoplasia over time and is
endorsed as an alternative to
colonoscopy in average-risk patients who
, agree to repeat testing and appropriate
follow-up colonoscopy for positive tests.
This aligns with CMDT recommendations
emphasizing patient preference and
adherence when choosing modality.
Rationale — Incorrect
B. Flexible sigmoidoscopy every 5 years
is less sensitive than colonoscopy for
proximal lesions and is not the preferred
alternative when FIT is available.
C. Colonoscopy is more sensitive but not
required if the patient prefers FIT and
will adhere to annual testing; immediate
colonoscopy is not mandatory.
D. Delaying screening until 55 is
inappropriate for average-risk adults;
screening should start at guideline-
TREATMENT 2026
65TH EDITION
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
1)
Reference
Ch. Disease Prevention & Health
Promotion — Colorectal Cancer
Screening: Age & Modality Selection
,Stem
A 52-year-old man with no symptoms
and no family history of colorectal cancer
presents for routine preventive care. He
has well-controlled hypertension and
prefers noninvasive testing. He asks
whether fecal immunochemical testing
(FIT) every year is acceptable versus
colonoscopy now. Which is the best
recommendation?
Options
A. Recommend annual FIT as equivalent
to colonoscopy and continue yearly FIT.
B. Recommend flexible sigmoidoscopy
every 5 years because it is less invasive
than colonoscopy.
C. Recommend colonoscopy now
,because he is over 50 and prefers the
most sensitive test.
D. Recommend no screening until age 55
because he is low risk.
Correct answer
A
Rationale — Correct (A)
Annual FIT is an accepted, evidence-
based screening option for average-risk
adults beginning at age 45–50
(depending on guideline) and is
appropriate for patients who prefer a
noninvasive strategy. When performed
annually, FIT yields high sensitivity for
advanced neoplasia over time and is
endorsed as an alternative to
colonoscopy in average-risk patients who
, agree to repeat testing and appropriate
follow-up colonoscopy for positive tests.
This aligns with CMDT recommendations
emphasizing patient preference and
adherence when choosing modality.
Rationale — Incorrect
B. Flexible sigmoidoscopy every 5 years
is less sensitive than colonoscopy for
proximal lesions and is not the preferred
alternative when FIT is available.
C. Colonoscopy is more sensitive but not
required if the patient prefers FIT and
will adhere to annual testing; immediate
colonoscopy is not mandatory.
D. Delaying screening until 55 is
inappropriate for average-risk adults;
screening should start at guideline-
